# MannKind

MannKind is an Asset Manager based in Danbury, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Danbury, United States
- **Region:** North America
- **Address:** Danbury, CT, United States
- **Founded:** 1991
- **Assets under management:** Undisclosed
- **Website:** mannkindcorp.com

## Regulatory record

- **Reports private funds:** No

## About

MannKind Corp was formed in 1991 by Alfred E. Mann, an entrepreneur who sold his first aerospace company in the 1960s before founding and exiting multiple medical-technology firms valued in the billions. The firm is often confused with the publicly traded biopharmaceutical company MannKind Corporation, an entity Mann funded and chaired but that operates as an independent drug-development business. The investment office is a separate structure, set up to manage a concentrated portfolio of public equities and operating assets on behalf of Mann's family interests. The firm deploys capital primarily through long-only public equity positions, with a documented concentration in energy-transition commodities and infrastructure. Regulatory filings have historically shown significant stakes in natural-resource companies and media distribution platforms. Known portfolio names from SEC records and company disclosures have included positions in Uranium Energy Corp, an American uranium mining and exploration company, and Entravision Communications, a Spanish-language media group with extensive broadcast and digital assets across the United States and Latin America. Geographic coverage spans North American markets, with Latin American media exposure through operating-company holdings. Team size and total deployment are not publicly disclosed. The firm operates from Danbury, Connecticut, and has not announced additional offices. Mann died in 2016, and management of the investment vehicle passed to a private trust structure. The firm has not publicized any separate philanthropic foundation, but Mann's charitable giving during his lifetime — including large gifts to the University of Southern California and Purdue University — was conducted through personal and trust-based vehicles distinct from the investment entity. No fund commitments, co-investment clubs, or adjacent operating businesses have been reported as part of the current corporate structure. What distinguishes MannKind Corp from conventional family offices is its instrument: a publicly traded holding company subject to SEC reporting requirements. That public-filing footprint forces a level of portfolio transparency uncommon among single-family investment vehicles, making 13F and proxy disclosures the primary window into how a late-stage billionaire's family office allocates capital when it seeks liquid, long-duration exposure rather than private-company growth equity.

## Sectors

- Energy Transition & Renewables
- Infrastructure
- Media & Entertainment

## People

- Alfred E. Mann — Founder

## Questions

### How is MannKind Corp related to the pharmaceutical company MannKind Corporation?

They share a founder but are distinct entities. Alfred Mann founded and funded both, but the biopharmaceutical firm (ticker MNKD) is a separate publicly traded drug company focused on inhaled therapies like Afrezza. MannKind Corp is the family investment vehicle, making public-equity investments in energy, commodities and media. The overlap in naming has caused persistent confusion in public records and data-vendor classification.

### Who controls investment decisions at MannKind Corp after Alfred Mann's death?

Control passed to a private trust structure following Mann's death in 2016. The trust's investment committee and named fiduciaries are not disclosed in public filings, and the firm has not appointed a high-profile CIO or managing principal. SEC filings show the trust maintains continuity in the portfolio's sector focuses — energy commodities, media assets — without signaling a strategic pivot.

### What happened to Alfred Mann's other investment vehicles?

Mann ran his business empire through a complex web of trusts, holding companies, and operating entities. His medical-device companies — MiniMed, Advanced Bionics, and Second Sight — were sold or taken public during his lifetime, with much of the proceeds channeled into MannKind Corp and into philanthropic gifts via the Alfred E. Mann Foundation. The foundation is legally separate from the investment vehicle and focuses on biomedical research grants, not shared investment operations.

## Related profiles

- [Goldman Sachs BDC](https://altss.com/profile/goldman-sachs-bdc-inc)
- [Calamos Convertible and High Income Fund](https://altss.com/profile/calamos-convertible-and-high-income-fund)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/mannkind-corp

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology